Synergy CHC (NASDAQ: SNYR) Expands FOCUSfactor® to UAE & Turkey — Ignites Global Growth and New Revenue Streams

Core Insights - Synergy CHC Corp. has expanded its international licensing deal with Gravity Pharma to include Turkey, alongside the UAE, for exclusive distribution of FOCUSfactor®, generating $2 million in upfront licensing revenue with additional performance-based royalties [1][2][5] Company Overview - Synergy CHC Corp. is a consumer health and wellness company known for its flagship brands, including FOCUSfactor®, a clinically tested brain health supplement, and Flat Tummy®, a lifestyle wellness brand for women [4] Strategic Growth - The licensing model in the UAE and Turkey allows Synergy to scale the FOCUSfactor® brand without diluting ownership or diverting focus from U.S. operations, retaining 100% ownership and global intellectual property [2] - The company is pursuing a high-margin, global expansion strategy through capital-efficient partnerships, positioning itself to capitalize on the growing demand for cognitive health solutions [3][5] Market Potential - The brain health market is projected to exceed $20 billion by 2030, indicating significant growth opportunities for Synergy CHC Corp. [5]